drugset / Trial / NCT04717674

[18F]FPIA PET/CT Imaging in Patients With Solid Tumours

NCT04717674 ↗

NaSingle-groupOpen-labelDiagnostic

Summary

The study will be a phase 2, open-label study in patients with solid tumours to explore the relationship between short-chain fatty acid uptake using \[18F\]FPIA PET/CT and tumour proliferation

Timeline

Start
2021-12-07
Primary completion
2024-08
Completion
2024-10

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]Fluoropivalate Diagnostic / imaging agent — —

Indications